AI-extracted claim
“Biotech investors and chief executives wrote a letter of concern about decisional volatility and turmoil at the FDA”
Analyzed on 2026-09-19T06:42:39+00:00 · Last updated 2026-09-19
Plain language: Insufficient evidence was found to render a verdict.
Credibility score
out of 100
Based on 1 source
Low confidence
Original context
Show passage from source article
In November, a long list of biotech investors and chief executives wrote a letter of concern about “decisional volatility” and turmoil at the F.D.A.
Extracted from: F.D.A. Refuses to Review Moderna Flu Vaccine , The New York Times
Evidence
This analysis is based on a single source. Confidence is low.
Bias distribution of supporting sources
Mean bias -0.20
Community Takes
No Takes have been written on this claim yet. Sign in to write a Take.